Detalhe da pesquisa
1.
Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.
Cancer
; 130(7): 1147-1157, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105653
2.
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.
Cancer
; 130(7): 1137-1146, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105655
3.
Group psychedelic therapy: empirical estimates of cost-savings and improved access.
Front Psychiatry
; 14: 1293243, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125286
4.
Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.
J Palliat Med
; 26(12): 1702-1708, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37590474
5.
Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.
JAMA Oncol
; 9(6): 864-866, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052904
6.
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
Clin Cancer Res
; 10(14): 4724-33, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15269145
7.
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days.
Cancer
; 103(9): 1932-8, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15800893
8.
STI571 (imatinib mesylate): the tale of a targeted therapy.
Anticancer Drugs
; 13(2): 111-4, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11901302